Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Expert Review of Clinical Immunology|July 28, 2011
Relevance of rituximab therapy in pemphigus vulgaris: analysis of current data and the immunologic basis for its observed responsesRon J Feldman, A Razzaque AhmedJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 22, 2018
Autoimmune Sequelae Following Rituximab Therapy: A Review of the Literature and Potential Immunologic MechanismsAnna E Kersh, Ron J FeldmanInternational Journal of Dermatology|January 12, 2007
Multiple keratoacanthomas in a young woman: report of a case emphasizing medical management and a review of the spectrum of multiple keratoacanthomasRon J Feldman, John C MaizeGiornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|December 6, 2019
Updates on diagnosis and management of autoimmune blistering diseasesEmily F Cole, Naveed Sami, Ron J FeldmanCleveland Clinic Journal of Medicine|June 5, 2012
UV protection and sunscreens: what to tell patientsPaul C Jou, Ron J Feldman, Kenneth J TomeckiJAMA Dermatology|August 3, 2017
Treatment of Hailey-Hailey Disease With Low-Dose NaltrexoneLauren N Albers, Jack L Arbiser, Ron J FeldmanDermatology Online Journal|May 23, 2023
An oral lesion masquerading as lichen planusDanielle E Mustin, Stephanie L Wetzel, Ron J FeldmanAnticancer Research|August 5, 2003
The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesisRon J Feldman, Victor I Sementchenko, Dennis K WatsonJournal of Drugs in Dermatology : JDD|March 5, 2024
Comparing Clinical Outcomes of Steroid-Sparing Therapy With Rituximab Versus Rituximab Alone in PemphigusDanielle E Mustin, Emily F Cole, Rebecca Leibowitz, et al.JAMA Dermatology|December 29, 2016
Rituximab Treatment for Recalcitrant Dermatitis HerpetiformisLauren N Albers, John J Zone, Benjamin K Stoff, et al.Pageof 3